Although ultrasound-guided injections are more commonly used in human clinical settings, their application in this animal study reflects an advancement in experimental methodology [1]
Scientific References Sikiric P, et al
COMPOUNDED MEDICATION DISCLOSURE: Compounded medications, including compounded semaglutide and tirzepatide, are not FDA-approved drugs and have not been evaluated by the U.S
Beyond weight loss, early exploratory data suggest potential benefits including: Reductions in HbA1c (a marker of blood sugar control) in people with type 2 diabetes Improvements in lipid profiles (cholesterol and triglycerides) Reductions in liver fat, which may be relevant for metabolic dysfunction-associated steatotic liver disease (MASLD, formerly NAFLD), though these findings are preliminary Possible cardiovascular benefits
This depends on several things
Products sold online "for research use only" are not approved, manufactured, or quality-controlled for human use, and buying them carries quality and legal risk